Additionally, suppression of ATG6, a crucial protein in the ATG6 and Vps-34 complex that promotes autophagosome formation, downregulates HER2 expression and enhances tamoxifen sensitivity in estrogen receptor-positive breast cancer cells in vitro (Gu et al., 2017). This evidence concerns the gene ERBB2 and breast carcinoma.